Report - IQWiG-Berichte – Nr. 469 Idelalisib (chronische lymphatische … · 2020-01-24 · Idelalisib, Rituximab, Ofatumumab, Leukemia – Lymphocytic – Chronic – B-Cell, Benefit Assessment

Please pass captcha verification before submit form